We have therefore interrogated the data from the FIT-based SBoSP to determine the f-Hb concentrations in women and men detected with CRC, taking into account the anatomical location of the main lesion within the large bowel and the pathological stage. This evidence concerns the gene GSTM1 and colorectal carcinoma.